Drägerwerk reports weaker Q3 earnings: Drägerwerk stock trades below EUR 98.40 Xetra close

Published on 10/23/2026 at 10:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 EBIT fell to EUR 48.00 million on October 14, 2026. Drägerwerk stock costs EUR 98.15 on October 23, 2026, 0.25 percent below its Xetra close.

Profitability and reporting dates

Preliminary third-quarter EBIT fell to EUR 48.00 million on October 14, 2026.
Safety Technology order intake rose 20.20 percent to EUR 452.00 million in the third quarter of 2026.
Drägerwerk stock trades at EUR 98.15 at 10:28 a.m. CEST at Lang & Schwarz on October 23, 2026, 0.25 percent below the Xetra close of October 22, 2026.
The third-quarter report is scheduled for October 29, 2026.

Frankfurter Börsen-Handelsraum mit digitalen Kursanzeigen für den Medizintechnik-Sektor — Drägerwerk AG & Co. KGaA Frankfurter Börse Handelsraum Medizintechnik Sektor Kursanzeigen Händler DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock costs EUR 98.15 on October 23, 2026, 0.25 percent below the Xetra close of October 22, 2026. The latest company update showed weaker quarterly profitability despite higher revenue and a confirmed full-year outlook.

According to Deutsche Boerse, Dragerwerk reported preliminary third-quarter 2026 EBIT of EUR 48.00 million on October 14, down from EUR 56.70 million in the same quarter of 2025. The figure included EUR 20.10 million in customs refunds, making the quality of the reported profit especially important for the next update.

Revenue grew while margins narrowed

Revenue rose 2.10 percent year over year to EUR 851.00 million in the third quarter of 2026, while the EBIT margin fell to 5.60 percent from 6.80 percent. The company said higher functional costs outweighed the lower revenue growth rate. Gross margin reached 47.50 percent, helped by the customs refunds.

The order picture was more constructive. Total order intake increased 8.20 percent to EUR 926.00 million in the third quarter of 2026. Safety Technology led the improvement, with currency-adjusted order intake up 20.20 percent to EUR 452.00 million, while Medical Technology order intake fell 3.00 percent to EUR 474.00 million.

What does the order growth mean?

The mix points to stronger demand in Dragerwerk's safety activities, but the earnings conversion remains the key test. The company confirmed its 2026 outlook for currency-adjusted revenue growth of 2.00 to 6.00 percent and an EBIT margin of 6.00 to 8.00 percent, according to the same October 14 release.

Two dates shape the next update

The company is scheduled to publish its third-quarter report on October 29, 2026, at 7:30 a.m. CET, followed by a conference call at 4:00 p.m. CET. The capital markets day is scheduled for November 18, 2026, in Lubeck, according to Drager.

Stock stays below its yearly high

Dragerwerk's euro quote remains within a 52-week range of EUR 66.00 to EUR 125.40, while market capitalization is EUR 1.8 billion as of October 23, 2026. For investors, the upcoming report must show whether the stronger safety order intake can offset cost pressure in the income statement.

The stock was trading at EUR 98.15 at Lang & Schwarz on October 23, 2026 at 10:28 a.m. CEST, 0.25 percent below the Xetra close of October 22, 2026 at EUR 98.40. The further course of trading is shown by the continuously updated real-time quote of Dragerwerk stock.